Center-Authored Papers

Filters: Author is Blau, C Anthony  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Time Factors
Kiem H-P, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B et al..  2004.  Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(3):389-95. Abstract
Tacrolimus
Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Kiem H-P, Blau AC.  2011.  Long-term regulation of genetically modified primary hematopoietic cells in dogs.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1287-94. Abstract
Stromal Cells
Miller CP, Urban ND, Blau AC.  2011.  Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.. Anticancer research. 31(4):1189-95. Abstract
Stem Cells
Kiem H-P, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B et al..  2004.  Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(3):389-95. Abstract
STAT5 Transcription Factor
Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban ND, Henke M, Blau AC.  2009.  Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.. Stem cells (Dayton, Ohio). 27(9):2353-61. Abstract
Shared Resources
Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban ND, Henke M, Blau AC.  2009.  Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.. Stem cells (Dayton, Ohio). 27(9):2353-61. Abstract
Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B et al..  2009.  Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.. Cell stem cell. 4(4):359-69. Abstract
Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Kiem H-P, Blau AC.  2011.  Long-term regulation of genetically modified primary hematopoietic cells in dogs.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1287-94. Abstract
Severe Combined Immunodeficiency
Kiem H-P, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B et al..  2004.  Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(3):389-95. Abstract
September 2011
Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CMA, Hubaud A, Stadler B, Choi M, Bar M et al..  2011.  HIF induces human embryonic stem cell markers in cancer cells.. Cancer research. 71(13):4640-52. Abstract
Okazuka K, Beard BC, Emery DW, Schwarzwaelder K, Spector MR, Sale GE, von Kalle C, Kiem H-P, Blau AC.  2011.  Long-term regulation of genetically modified primary hematopoietic cells in dogs.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1287-94. Abstract
Scientific Imaging Core Facility
Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau AC, Emery DW.  2015.  A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.. Blood. 125(6):1025-33. Abstract
RNA, Untranslated
Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B et al..  2009.  Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.. Cell stem cell. 4(4):359-69. Abstract
RNA, Messenger
Miller CP, Urban ND, Blau AC.  2011.  Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.. Anticancer research. 31(4):1189-95. Abstract
Reverse Transcriptase Polymerase Chain Reaction
Miller CP, Urban ND, Blau AC.  2011.  Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.. Anticancer research. 31(4):1189-95. Abstract
Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban ND, Henke M, Blau AC.  2009.  Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.. Stem cells (Dayton, Ohio). 27(9):2353-61. Abstract
Retroviridae
Kiem H-P, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B et al..  2004.  Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(3):389-95. Abstract
Receptors, Thrombopoietin
Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau AC, Emery DW.  2015.  A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.. Blood. 125(6):1025-33. Abstract
Receptors, Erythropoietin
Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban ND, Henke M, Blau AC.  2009.  Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.. Stem cells (Dayton, Ohio). 27(9):2353-61. Abstract
Miller CP, Urban ND, Blau AC.  2011.  Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.. Anticancer research. 31(4):1189-95. Abstract
Public Health Sciences Division
Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban ND, Henke M, Blau AC.  2009.  Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.. Stem cells (Dayton, Ohio). 27(9):2353-61. Abstract
Miller CP, Urban ND, Blau AC.  2011.  Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.. Anticancer research. 31(4):1189-95. Abstract
Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B et al..  2009.  Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.. Cell stem cell. 4(4):359-69. Abstract
Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng W-Y, Ou Yang T-H, Anastassiou D, Beatty JD, Urban ND, Blau AC.  2014.  JAK2 Expression Is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors.. Cancer immunology research. 2(4):301-6. Abstract
Platelet Membrane Glycoprotein IIb
Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau AC, Emery DW.  2015.  A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.. Blood. 125(6):1025-33. Abstract